Blood test could spare cancer patients from unnecessary side effects

NCT ID NCT07558083

Recruiting now Knowledge-focused Sponsor: University Hospital, Antwerp Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether using a blood test (liquid biopsy) to monitor treatment response can help people with advanced colorectal cancer maintain a better quality of life. Instead of relying only on CT scans, doctors will use the blood test to adjust treatment earlier and more personally. The study involves 150 adults starting their first treatment for metastatic colorectal cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED COLORECTAL CANCER

Contacts and locations

Locations

AZ Groeninge, Kortrijk
RECRUITING

Kortrijk, West-Vlaanderen, 8500, Belgium
AZ Klina
RECRUITING

Brasschaat, Antwerp, 2930, Belgium
AZ Maria Middelares, Ghent
RECRUITING

Ghent, Oost-Vlaanderen, 9000, Belgium
AZ Sint Lucas, Brugge
RECRUITING

Bruges, West-Vlaanderen, 8000, Belgium
AZ Sint Maarten
RECRUITING

Mechelen, Antwerpen, 2800, Belgium
Grand Hopital de Charleroi
RECRUITING

Charleroi, Henegouwen, 6020, Belgium
Sint-Augustinus (ZAS)
RECRUITING

Wilrijk, Antwerp, 2610, Belgium
University Hospital Antwerp
RECRUITING

Edegem, Antwerp, 2650, Belgium
Vitaz
RECRUITING

Sint-Niklaas, Oost-Vlaanderen, 9100, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.